Endometrial Cancer

Showing NaN - NaN of 61

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, Endometrial Cancer Trial in Oklahoma City, Houston (AO-252)

Recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Oklahoma City, Oklahoma
  • +1 more
Nov 13, 2023

Endometrial Cancer Trial in Houston (Paclitaxel, Carboplatin, Dostarlimab)

Not yet recruiting
  • Endometrial Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Apr 6, 2023

Endometrial Cancer Trial in Houston (DKN-01, Pembrolizumab)

Not yet recruiting
  • Endometrial Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 27, 2023

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Endometrial Cancer Who Receive Standard Treatment for Their

Recruiting
  • Endometrial Cancer
  • +2 more
  • Physical exam
  • Hartford, Connecticut
  • +19 more
Jan 19, 2023

Gynecologic Cancer, Ovary Cancer, Pancreatic Cancer Trial in Houston (Free genetic testing and counseling group, IGNITE-TX

Not yet recruiting
  • Gynecologic Cancer
  • +8 more
  • Free genetic testing and counseling group
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Jan 11, 2023

Ovarian Cancer, Cervical Cancer, Endometrial Cancer Trial in Worldwide (Enapotamab vedotin (HuMax-AXL-ADC))

Completed
  • Ovarian Cancer
  • +7 more
  • Enapotamab vedotin (HuMax-AXL-ADC)
  • Phoenix, Arizona
  • +40 more
Dec 12, 2022

Biliary Tract Cancer (BTC), Colorectal Cancer (CRC), Endometrial Cancer Trial in Belgium, United Kingdom, United States

Completed
  • Biliary Tract Cancer (BTC)
  • +5 more
  • Birmingham, Alabama
  • +9 more
Dec 22, 2022

Advanced Solid Malignancy, Safety and Tolerability, Pharmacokinetics Trial in Worldwide (AZD5363)

Active, not recruiting
  • Advanced Solid Malignancy
  • +13 more
  • Los Angeles, California
  • +33 more
Dec 22, 2022

Endometrial Cancer Trial in Morristown, Houston (Letrozole, RAD001 (Everolimus))

Active, not recruiting
  • Endometrial Cancer
  • Morristown, New Jersey
  • +1 more
Nov 16, 2022

Breast Cancer, Cholangiocarcinoma, Ovarian Cancer Trial in Worldwide (AZD8205)

Recruiting
  • Breast Cancer
  • +3 more
  • Duarte, California
  • +12 more
Oct 31, 2022

Ovarian Cancer, Breast Cancer, Solid Tumor Trial in Houston, Brisbane (CYH33)

Recruiting
  • Ovarian Cancer
  • +4 more
  • New Haven, Connecticut
  • +6 more
Oct 10, 2022

Endometrial Cancer, Ovarian Cancer Trial in Houston (Copanlisib, fulvestrant)

Recruiting
  • Endometrial Cancer
  • Ovarian Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2022

ENDOMETRIAL CANCER Trial in Cleveland, Houston (Surgery with UM, Surgery without UM)

Recruiting
  • ENDOMETRIAL CANCER
  • Surgery with UM
  • Surgery without UM
  • Cleveland, Ohio
  • +4 more
Sep 6, 2022

Cancer, Solid Tumor, Solid Carcinoma Trial in Houston (AMXT1501, DFMO)

Recruiting
  • Cancer
  • +18 more
  • Houston, Texas
    MD Anderson Cancer Center
Aug 12, 2022

Endometrial Cancer, Gastric Cancer, Metastatic Castration-resistant Prostate Cancer Trial in Worldwide (Datopotamab deruxtecan

Not yet recruiting
  • Endometrial Cancer
  • +4 more
  • Datopotamab deruxtecan (Dato-DXd)
  • +8 more
  • Los Angeles, California
  • +52 more
Aug 3, 2022

Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

Recruiting
  • Gynecologic Cancer
  • +11 more
  • Neoantigen specific TCR-T cell drug product
  • Aldesleukin (IL-2)
  • Houston, Texas
    MD Anderson Cancer Center
Jul 27, 2022

HLA Typing and Tumor Neoantigen Identification forPhase I/II

Recruiting
  • Ovarian Cancer
  • +5 more
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 27, 2022

    Endometrial Cancer Trial in Worldwide (retifanlimab, epacadostat, pemigatinib)

    Recruiting
    • Endometrial Cancer
    • Anchorage, Alaska
    • +78 more
    Jul 25, 2022

    Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

    Recruiting
    • Ovarian Cancer
    • +12 more
    • San Francisco, California
    • +44 more
    Jul 12, 2022